This HTML5 document contains 58 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n6http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q69227825
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована у вересні 1987 im September 1987 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel artículu científicu espublizáu en setiembre de 1987 scientific article published on 01 September 1987
p:P577
wds:Q69227825-F241C71E-0D17-4843-A383-9C6F1C7CBD82
wdt:P577
1987-09-01T00:00:00Z
p:P407
wds:Q69227825-8D88582B-EDF2-4FD7-8601-F46BB6B52300
wdt:P407
wd:Q1860
p:P2093
wds:Q69227825-A782C584-BE7A-4930-8B21-C8CDAA1EE080 wds:Q69227825-AB1EB28B-1AA7-4F13-ADD4-2A1F65C4F07D wds:Q69227825-ACA8338B-DF39-402F-97E6-040E51B60EE5 wds:Q69227825-BBFC0A8A-89E5-4B84-8A06-14B2C7F77548 wds:Q69227825-67FF4FE3-8B58-4547-B77C-E6E043D170CA wds:Q69227825-629EADAA-E019-4DA6-96B8-B7036BB90CD9 wds:Q69227825-8F21F104-C936-46B9-B936-B5A0B6D8E2CD wds:Q69227825-7EF44F11-107C-4C13-94A6-120E3B449890 wds:Q69227825-09F40FE1-B91F-4CBD-BB58-680EDAA99A4D wds:Q69227825-EDE8B7B1-79B2-4E72-98E7-C7DB855354A9
wdt:P2093
N K Cheung S Kallick H Lazarus S E Strandjord F D Miraldi C R Abramowsky T Spitzer N A Berger P F Coccia U M Saarinen
rdfs:label
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma
skos:prefLabel
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma
schema:name
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma
p:P1476
wds:Q69227825-8B192E3B-CA3D-4E13-9D64-0A0BC569C95E
wdt:P1476
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma
p:P304
wds:Q69227825-BD0B37EF-044B-4147-92EC-1C98CCC2FFE6
wdt:P304
1430-1440
p:P31
wds:Q69227825-33F576C2-F0C0-416B-86A6-84117353D530
wdt:P31
wd:Q13442814
p:P921
wds:Q69227825-9F82F07C-0965-47BF-B037-C5E4CEBA5142 wds:Q69227825-D759AB5F-8458-41EC-88ED-50BD88861D6B
wdt:P921
wd:Q422248 wd:Q938205
p:P698
wds:Q69227825-989AEEBB-AB32-4BF5-AD79-DB400100C2BB
wdtn:P698
n11:3625258
wdt:P698
3625258
p:P1433
wds:Q69227825-EA53AF95-EE1D-462D-8446-EF8A256FA0C9
wdt:P1433
wd:Q400292
p:P433
wds:Q69227825-29697E35-9D94-40CE-BC64-890F60A84AB1
p:P478
wds:Q69227825-6DEA5025-FF09-4D13-9148-66DEA5621BD1
wdt:P433
9
wdt:P478
5
p:P356
wds:Q69227825-2DA6F456-A0B4-4A4C-B9EF-6C63D0F0C7E3
wdtn:P356
n6:JCO.1987.5.9.1430
wdt:P356
10.1200/JCO.1987.5.9.1430